Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-04 · accession 0000899243-22-016538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-04 | 2022-05-04 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $1.69 | +20.0K | 57.3K | +54% | +$33.7K |
| DM | 2022-05-04 | 2022-05-04 | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $0.00 | -20.0K | 109.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-04 | M | A | 10,208 | $1.31 | 47,465 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-04 | M | A | 9,792 | $2.08 | 57,257 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-05-04 | M | D | 10,208 | $0.00 | 29,799 | D | $1.31 · — to 2028-10-31 | 10,208 Common Stock | (F1) Twenty-five percent (25%) of the shares underlying this stock option vested on September 12, 2019 and the remaining shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-05-04 | M | D | 9,792 | $0.00 | 109,020 | D | $2.08 · — to 2029-05-22 | 9,792 Common Stock | (F2) The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date. |